Management of Skin Sores from Itching in Autoimmune Hepatitis
Start rifampicin 150 mg twice daily as first-line treatment for the pruritus, while simultaneously managing the skin sores with emollients and wound care to prevent secondary infection. This approach addresses both the underlying hepatic itch and its dermatologic consequences.
Treating the Underlying Pruritus
The British Association of Dermatologists 2018 guidelines provide clear, evidence-based recommendations for hepatic pruritus that directly apply to autoimmune hepatitis 1:
Stepwise Pharmacologic Approach:
First-line: Rifampicin (Strength of recommendation A)
- Start at 150 mg twice daily, can increase to 600 mg twice daily 1
- Supported by two meta-analyses showing effectiveness in reducing hepatic pruritus 1
- Monitor for hepatotoxicity - this is critical in autoimmune hepatitis patients already at risk
- Warn patients about discoloration of secretions (tears, urine, sweat) 1
Second-line: Cholestyramine 9 g daily orally 1
- Binds bile salts in the gut lumen
- Limited evidence but traditionally used
- May interfere with absorption of immunosuppressive medications - dose separately by at least 4 hours
Third-line: Sertraline 75-100 mg daily 1
- Well tolerated in hepatic pruritus
- Should be used before opioid antagonists
Fourth-line: Naltrexone or nalmefene 1
- Significantly more side effects than earlier options
- Reserve for refractory cases
Avoid gabapentin - specifically contraindicated in hepatic pruritus 1
Managing the Skin Sores
Immediate Wound Care:
- Apply emollients liberally and frequently to restore skin barrier function 1
- Gentle cleansing with non-irritating cleansers
- Keep nails trimmed short to minimize trauma from scratching
- Consider occlusive dressings for open sores to promote healing and prevent infection
Topical Therapy Options:
- Topical tacrolimus ointment may be considered as a fifth-line option for both pruritus and skin inflammation 1
- Topical clobetasone butyrate (mild corticosteroid) for inflamed, excoriated areas 1
- Topical menthol for cooling effect 1
Infection Prevention:
Monitor for signs of secondary bacterial infection (increased erythema, purulence, warmth). Patients on immunosuppressive therapy for autoimmune hepatitis are at higher risk for skin infections.
Adjunctive Therapies
Phototherapy may provide additional benefit:
- Broadband UVB or combined UVA/UVB can relieve cholestatic pruritus 1
- Consider if pharmacologic therapy is insufficient
Behavioral interventions 1:
- Education on avoiding trigger factors
- Habit reversal training to reduce scratching behavior
- Relaxation techniques
- Cool compresses during severe itch episodes
Critical Monitoring Considerations
Given that this patient likely has autoimmune hepatitis on immunosuppressive therapy 2:
- Hepatotoxicity monitoring is essential when using rifampicin - check liver enzymes regularly
- Drug interactions: Rifampicin is a potent CYP450 inducer and may reduce levels of azathioprine, mycophenolate, or corticosteroids
- Coordinate with hepatology before initiating rifampicin to adjust immunosuppressive dosing if needed 1
Common Pitfalls to Avoid
- Do not use antihistamines - they are ineffective for hepatic pruritus 3
- Avoid sedating antihistamines long-term - may predispose to dementia 1
- Do not delay treatment - chronic scratching leads to lichen simplex chronicus and increases infection risk 4
- Do not assume pruritus correlates with disease severity - it can occur regardless of cholestasis extent 3
Algorithm Summary
- Initiate rifampicin 150 mg twice daily with hepatotoxicity monitoring
- Simultaneously apply emollients liberally to all affected skin
- Provide wound care for open sores with infection surveillance
- If inadequate response at 4-6 weeks: Add cholestyramine (dosed away from other medications)
- If still inadequate: Progress to sertraline, then naltrexone
- Consider phototherapy as adjunct at any stage
- Implement behavioral modifications throughout
The pruritus in autoimmune hepatitis can be severe and debilitating 5, but this systematic approach targeting the hepatic source while managing skin complications offers the best chance for symptom control and quality of life improvement.